SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-359062
Filing Date
2012-08-16
Accepted
2012-08-16 16:06:00
Documents
16
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d347756d10q.htm 10-Q 245394
2 EX-10.128 d347756dex10128.htm EX-10.128 291043
3 EX-10.129 d347756dex10129.htm EX-10.129 159988
4 EX-31.1 d347756dex311.htm EX-31.1 10168
5 EX-31.2 d347756dex312.htm EX-31.2 10183
6 EX-32 d347756dex32.htm EX-32 5694
13 GRAPHIC g347756001.jpg GRAPHIC 2684
14 GRAPHIC g347756002.jpg GRAPHIC 12036
15 GRAPHIC g347756003.jpg GRAPHIC 2051
16 GRAPHIC g347756004.jpg GRAPHIC 1250
  Complete submission text file 0001193125-12-359062.txt   2248174

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT corx-20120630.xml EX-101.INS 144939
8 XBRL TAXONOMY EXTENSION SCHEMA corx-20120630.xsd EX-101.SCH 18242
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE corx-20120630_cal.xml EX-101.CAL 32676
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE corx-20120630_def.xml EX-101.DEF 20506
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE corx-20120630_lab.xml EX-101.LAB 188856
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE corx-20120630_pre.xml EX-101.PRE 124703
Mailing Address 15241 BARRANCA PARKWAY IRVINE CA 92718
Business Address 15241 BARRANCA PKWY IRVINE CA 92718 7147273157
CORTEX PHARMACEUTICALS INC/DE/ (Filer) CIK: 0000849636 (see all company filings)

IRS No.: 330303583 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-16467 | Film No.: 121040156
SIC: 2834 Pharmaceutical Preparations